3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
28
Gastrointestinal Stromal Tumors
4
Colonic Neoplasms
4
Carcinoma, Hepatocellular
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasms
3
Neoplasm Metastasis
3
Rectal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Bile Duct Neoplasms
2
Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Renal Insufficiency
1
Physician Education
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Noonan Syndrome 6
1
Metastatic Pancreatic Adenocarcinoma
1
Melanoma
1
Liver Neoplasms
1
Liposarcoma
1
Insulinoma
1
Interventions
Epoetin Alfa
7
Darbepoetin alfa
6
epoetin beta
4
Lenalidomide
4
Cyclophosphamide
4
ACE-011
4
fludarabine
3
Busulfan
3
thymoglobulin
2
telapristone acetate
2
luspatercept
2
fludarabine phosphate
2
Cyclosporine
2
Antilymphocyte Serum
2
AP 1903 reagent
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
vactosertib
1
ruxolitinib
1
roxadustat
1
obinutuzumab
1
ibrutinib
1
fosphenytoin
1
ferrous sulfate
1
ferric gluconate
1
ferric carboxymaltose
1
eltrombopag
1
angiotensin I (1-7)
1
Whole-Body Irradiation
1
Thiotepa
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia
×
regorafenib
×
Clear all
No trials found.